CoChat

Blockchain protocols in clinical trials: Transparency and traceability of consent

Open access
Benchoufi, Mehdi, Porcher, Raphael, Ravaud, Philippe · 2017 · F1000Research
Cited by 78

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Clinical trial consent for protocols and their revisions should be transparent for patients and traceable for stakeholders. Our goal is to implement a process allowing the collection of patients’ informed consent, which is bound to protocol revisions, storing and tracking the consent in a secure, unfalsifiable and publicly verifiable way, and enabling the sharing of this information in real time. For that, we will built a consent workflow using a rising technology called Blockchain. This is a distributed technology that brings a built-in layer of transparency and traceability. Additionally, it removes the need for third parties, and gives participative control to the peer-to-peer users. From a more general and prospective point of view, we believe Blockchain technology brings a paradigmatical shift to the entire clinical research field. We designed a Proof-of-Concept protocol consisting of time-stamping each step of the patient’s consent collection using Blockchain; thus archiving and historicising the consent through cryptographic validation in a securely unfalsifiable and transparent way. For each revision of the protocol, consent was sought again. We obtained a single document, in a standard open format, that accounted for the whole consent collection process: timestamped consent status with regards to each version of the protocol. This document cannot be corrupted, and can be checked on any dedicated public website. It should be considered as a robust proof of data. In the future, we think that the complex data flow of a clinical trial can be tracked using Blockchain. Moreover, a blockchain core functionality, named Smart Contract, can help prevent clinical trial events not to happen in the right chronological order: including patients before they consented or analysing case report forms data before freezing the database. This will help reaching reliability, security, and transparency, and could be a consistent step towards reproducibility.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.12688/f1000research.10531.1

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 15

  1. U Gupta, 2013, Informed consent in clinical research: Revisiting few concepts and areas., Perspect Clin Res., 4, 26-32, 10.4103/2229-3485.106373 · DOI · Paper page
  2. C Seife, 2015, Research misconduct identified by the US Food and Drug Administration: out of sight, out of mind, out of the peer-reviewed literature., JAMA Intern Med., 175, 567-77, 10.1001/jamainternmed.2014.7774 · DOI · Paper page
  3. L Dillner, 1996, BSE linked to new variant of CJD in humans., BMJ., 312, 795-800, 10.1136/bmj.312.7034.795 · DOI
  4. P Myles, 2014, Ethical and scientific considerations for patient enrollment into concurrent clinical trials., Trials., 15, 470, 10.1186/1745-6215-15-470 · DOI · Paper page
  5. U Gupta, 2013, Informed consent in clinical research: Revisiting few concepts and areas., Perspect Clin Res., 4, 26-32, 10.4103/2229-3485.106373 · DOI · Paper page
  6. D Resnik, 2009, Re-consenting human subjects: Ethical, legal and practical issues., J Med Ethics., 35, 656-657, 10.1136/jme.2009.030338 · DOI
  7. G Swanson, 1995, Recruiting minorities into clinical trials: toward a participant-friendly system., J Natl Cancer Inst., 87, 1747-59, 10.1093/jnci/87.23.1747 · DOI · Paper page
  8. L Lovato, 1997, Recruitment for controlled clinical trials: literature summary and annotated bibliography., Control Clin Trials., 18, 328-52, 10.1016/S0197-2456(96)00236-X · DOI · Paper page
  9. R Hazen, 2010, A feasibility trial of a video intervention to improve informed consent for parents of children with leukemia., Pediatr Blood Cancer., 55, 113-8, 10.1002/pbc.22411 · DOI
  10. J Brehaut, 2012, Informed consent documents do not encourage good-quality decision making., J Clin Epidemiol., 65, 708-724, 10.1016/j.jclinepi.2012.01.004 · DOI
  11. A Pandiya, 2010, Readability and comprehensibility of informed consent forms for clinical trials., Perspect Clin Res., 1, 98-100, 10.4103/2229-3485.71864 · DOI · Paper page
  12. A Paris, 2010, Informed consent document improvement does not increase patients' comprehension in biomedical research., Br J Clin Pharmacol., 69, 231-237, 10.1111/j.1365-2125.2009.03565.x · DOI · Paper page
  13. E Mills, 2006, Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors., Lancet Oncol., 7, 141-148, 10.1016/S1470-2045(06)70576-9 · DOI · Paper page
  14. M Eder, 2007, Improving informed consent: suggestions from parents of children with leukemia., Pediatrics., 119, e849-59, 10.1542/peds.2006-2208 · DOI · Paper page
  15. R Smyth, 2012, Deciding to join a perinatal randomised controlled trial: experiences and views of pregnant women enroled in the Magpie Trial., Midwifery., 28, E478-85, 10.1016/j.midw.2011.08.006 · DOI

Cited by

See all 78

Metadata

Authors
Benchoufi, M., Porcher, R., & Ravaud, P.
Venue
F1000Research
Published
2017-01-23
Volume
6
Pages
66
ISSN
2046-1402 (ISSN-L)
OpenAlex
W4239439314
Cited by
78
References
3
FWCI
16.81
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blockchain protocols in clinical trials: Transparency and traceability of consent. https://app.cochat.ai/papers/10.12688/f1000research.10531.1
The paper
Benchoufi, M., Porcher, R., & Ravaud, P. (2017). Blockchain protocols in clinical trials: Transparency and traceability of consent. F1000Research. https://doi.org/10.12688/f1000research.10531.1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.